Details for: CL0002538

Cell ID: CL0002538

Cell Name: intrahepatic cholangiocyte

Description: An epithelial cell of the intrahepatic portion of the bile duct. These cells are flattened or cuboidal in shape, and have a small nuclear-to-cytoplasmic ratio relative to large/extrahepatic cholangiocytes.

Synonyms: small bile duct cholangiocyte

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for intrahepatic cholangiocyte within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for intrahepatic cholangiocyte. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for intrahepatic cholangiocyte. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for intrahepatic cholangiocyte. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  intrahepatic cholangiocyte (CL0002538)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [intrahepatic cholangiocyte](/details-cell/CL0002538) is an epithelial cell lining the small bile ducts within the liver. Based on its gene significance profile, this cell type is characterized by an exceptionally high level of metabolic activity, specifically in mitochondrial energy production, and robust machinery for RNA processing and protein synthesis. The high specificity scores (`csi_z`) for numerous mitochondrially-encoded genes and RNA-binding proteins suggest these fundamental processes are not just active but are defining features that distinguish these cells from other hepatic cell types. This profile paints a picture of a highly active, biosynthetic, and secretory cell essential for the modification and transport of bile. ## Key Characteristics and Function The functional identity of the [intrahepatic cholangiocyte](/details-cell/CL0002538) is underscored by several clusters of specifically expressed genes. * **Mitochondrial Bioenergetics:** A prominent feature is the high significance of genes involved in oxidative phosphorylation. This includes multiple subunits of the NADH dehydrogenase complex ([ND1](/details-gene/4535), [ND2](/details-gene/4536), [ND3](/details-gene/4537), [ND4](/details-gene/4538)), ATP synthase ([ATP6](/details-gene/4508), [ATP5MC2](/details-gene/517)), and cytochrome c oxidase ([COX6C](/details-gene/1345)). This strong signature of aerobic respiration is consistent with a high energy demand required to fuel active transport across the epithelial barrier, a primary function in bile formation. * **RNA Processing and Protein Synthesis:** The top marker, [HNRNPA2B1](/details-gene/3181), along with other highly significant genes like [DDX5](/details-gene/1655), [PABPC1](/details-gene/26986), and the long non-coding RNA [NEAT1](/details-gene/283131), highlights the critical role of RNA splicing, stability, and regulation in these cells. This is complemented by the high specificity of translation elongation factors ([EEF1B2](/details-gene/1933), [EEF1D](/details-gene/1936)), indicating a high capacity for protein production, likely for both internal structural/enzymatic needs and secreted components of bile. * **Cellular Structure and Signaling:** The presence of [B2M](/details-gene/567) as a marker suggests that these cells actively participate in immune surveillance via MHC class I antigen presentation. The high specificity of the epithelial transcription factor [ELF3](/details-gene/1999) points to a key regulator of their specialized epithelial identity. Furthermore, the significance of polyamine metabolism, indicated by [SAT1](/details-gene/6303), may be linked to the regulation of cell growth, differentiation, and response to cellular stress. * **Negative Markers:** **Overall**, the anti-marker profile is highly informative. The lack of specific expression for genes characteristic of hepatocytes, such as those for amino acid metabolism ([TAT](/details-gene/6898), [HGD](/details-gene/3081)), S-adenosylmethionine synthesis ([MAT1A](/details-gene/4143)), and organic anion transport ([SLCO1B1](/details-gene/10599)), clearly delineates the [intrahepatic cholangiocyte](/details-cell/CL0002538) as a distinct lineage from the liver parenchymal cells. This confirms their specialized role in ductal transport rather than systemic metabolic processing. ## Clinical Significance and Contextual Roles The gene expression profile of [intrahepatic cholangiocytes](/details-cell/CL0002538) provides insights into their potential roles in liver pathology. The profound reliance on mitochondrial function suggests these cells may be particularly vulnerable to mitochondrial toxins or ischemic injury, conditions often associated with cholestatic liver diseases like primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). The high specificity of [HMGB1](/details-gene/3146), a well-known damage-associated molecular pattern (DAMP) molecule, suggests that when these cells are damaged, they may be potent initiators of the sterile inflammation that drives the progression of these diseases. Furthermore, several top markers are implicated in cancer biology. [ELF3](/details-gene/1999) is an ETS-family transcription factor whose dysregulation has been linked to epithelial malignancies ([Link](https://doi.org/10.1038/sj.onc.1200978)). Its defining expression in cholangiocytes could imply a central role in the development or progression of cholangiocarcinoma, the cancer arising from these cells. Similarly, alterations in the expression of RNA-binding proteins like [HNRNPA2B1](/details-gene/3181) and DEAD-box helicases like [DDX5](/details-gene/1655) are known to contribute to tumorigenesis through aberrant splicing and gene regulation. The specific expression of these genes in [intrahepatic cholangiocytes](/details-cell/CL0002538) positions them as potential therapeutic targets or biomarkers for this aggressive cancer. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The defining metabolic signature of [intrahepatic cholangiocytes](/details-cell/CL0002538) is an exceptionally high and specific dependence on oxidative phosphorylation, rendering them uniquely vulnerable to mitochondrial insults that precipitate cholestatic liver injury. * **Surprising Findings:** It is notable that core, ubiquitously expressed mitochondrial genes serve as the most specific markers for this cell type. This suggests that the regulation and sheer level of mitochondrial gene expression, rather than the expression of unique metabolic enzymes, is a primary feature of the cholangiocyte's identity, distinguishing it from the surrounding hepatocytes which have a more diverse metabolic portfolio. * **Testable Questions:** How do the bioenergetic profiles (e.g., oxygen consumption rate and extracellular acidification rate) of isolated [intrahepatic cholangiocytes](/details-cell/CL0002538) change in response to bile acid-induced stress, and can these changes be rescued by mitochondrial-targeted antioxidants? 2. **Hypothesis:** A complex network of post-transcriptional regulation, driven by highly specific RNA-binding proteins such as [HNRNPA2B1](/details-gene/3181) and the lncRNA [NEAT1](/details-gene/283131), is essential for maintaining cholangiocyte identity and barrier function, and its disruption is an early event in the metaplastic changes leading to cholangiocarcinoma. * **Surprising Findings:** The emergence of a general RNA-binding protein like [HNRNPA2B1](/details-gene/3181) as the top specificity marker is unexpected. This may indicate that cholangiocytes utilize a unique repertoire of alternative splicing events, controlled by [HNRNPA2B1](/details-gene/3181), to generate protein isoforms crucial for their specialized ductal functions. * **Testable Questions:** Does RNA-sequencing analysis following siRNA-mediated knockdown of [HNRNPA2B1](/details-gene/3181) in cholangiocyte organoids reveal specific splicing changes in genes related to cell adhesion, ion transport, or cell polarity, and do these changes compromise epithelial barrier integrity?